The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vitamin C Derivative Promising Option for OA

Vitamin C Derivative Promising Option for OA

August 24, 2015 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Clinical_500x270Several studies have suggested that antioxidants, such as N-acetyl cysteine (NAC) and procyanids, are able to attenuate the development of instability-induced osteoarthritis (OA) in mice. Moreover, vitamin C has been shown to promote the synthesis of type II collagen and aggrecan in cartilage explants from guinea pigs. These results have led investigators to suggest that vitamin C might have beneficial effects on cartilage degeneration.

You Might Also Like
  • Can Lubricating Joints Prevent Osteoarthritis?
  • Adenosine Treatment Promotes Cartilage Homeostasis
  • Hyaluronidase 2 May Play an Important Role in OA Progression
Also By This Author
  • Mind-Body Techniques for Pain Management

Masato Koike, MD, PhD, professor and chairman of the Department of Cell Biology and Neuroscience in the Juntendo University Graduate School of Medicine in Tokyo, Japan, and colleagues published the results of their mouse study in Scientific Reports online on June 25.1 They found that mitochondrial superoxide appears to play a pivotal role in the development and progression of osteoarthritis. They began their research with normal 20-week-old, C57BL/6 mice and performed surgical destabilization of the medial meniscus (DMM). This procedure induced abnormal loading in the chondrocytes of the knee cartilage. The investigators then evaluated the gene expression of several superoxide-degrading enzyme genes (Sod1, Sod2 and Sod3).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We discovered that abnormal loading significantly elevated mitochondrial superoxide generation and down-regulated the Sod2 expression in wild-type chondrocytes from the DMM side compared with the sham side before the appearance of obvious cartilage degeneration in vivo, suggesting a negative correlation between the mitochondrial superoxide leak and Sod2 decline,” wrote the researchers.

Paraquat (PQ) is a mitochondrial superoxide inducer at I26. The investigators treated the mice with PQ and were able to induce mitochondrial superoxide generation at complex I26 and significantly suppress Sod2 expression in wild-type chondrocytes from the DMM side when compared to chondrocytes from the sham side. The suppression occurred even prior to obvious cartilage degeneration in vivo.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We have, for the first time, demonstrated that SOD2 loss in chondrocytes accelerated cartilage degeneration during aging and under an instability murine model,” emphasized the authors in their discussion.

They then investigated the expression of OA-related genes in PQ-treated mice. The results suggested that PQ treatment suppressed the gene expression of antioxidant enzymes, including Sod2. This then resulted in impaired extracellular matrix (ECM) metabolism.

To further investigate the OA phenotypes of cartilage and chondrocytes, the investigators created chondrocyte-specific, Sod2-deficient mice that had mitochondrial superoxide overproduction and dysfunction. They examined Sod2 loss in chondrocytes-accelerated cartilage degeneration during aging and found that the Sod2-deficient mice did have accelerated cartilage degeneration relative to control littermates.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We selected a stable, permeable and less toxic vitamin C derivative to suppress mitochondrial superoxide generation in chondrocytes in vivo,” explained the authors. When the investigators injected the permeable antioxidant L-ascorbyl 2-phosphate 6-palmitate (APPS) into the intra-articular space, they were able to effectively suppress mechanical-loading-induced mitochondrial superoxide generation, as well as cartilage degeneration in the mice. The authors concluded their paper by suggesting that mitochondrial superoxide balance may be a promising therapeutic target for cartilage degeneration. They also propose further investigation into the effects of an intra-articular injection of a vitamin C derivative to reduce cartilage degeneration.

Pages: 1 2 | Single Page

Filed Under: Conditions, Osteoarthritis Tagged With: cartilage, chondrocyte, osteoarthritis (OA), Vitamin C

You Might Also Like:
  • Can Lubricating Joints Prevent Osteoarthritis?
  • Adenosine Treatment Promotes Cartilage Homeostasis
  • Hyaluronidase 2 May Play an Important Role in OA Progression
  • Low Levels of Vitamin D3 May Increase OA Pain

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.